Incyte's experimental skin disease drug met the main goal of two separate late-stage trials, but data showed that it was not as effective as in its prior studies, sending the drugmaker's shares down ...

It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...

Cosentyx (secukinumab ... always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended ...

A comparative study will be conducted to demonstrate the efficacy, safety, and equivalence between Cosentyx and CT-P55. CT-P55 received IND approval from the U.S. Food and Drug Administration (FDA ...